Using an online DNA microarray database at the ONCOMINE website, we found higher mRNA level of TMCC3 in cancer part than normal tissue in cervical cancer, prostate cancer, pancreatic cancer, lung cancer, glioblastoma, skin cancer, hepatoma, and thyroid gland papillary carcinoma (Supplementary Fig. S6a). This evidence concerns the gene TMCC3 and prostate carcinoma.